Parametric Portfolio Associates’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$1.24M Buy
216,477
+41,299
+24% +$236K ﹤0.01% 2681
2021
Q4
$1.6M Sell
175,178
-2,594
-1% -$23.7K ﹤0.01% 2577
2021
Q3
$1.9M Buy
177,772
+17,440
+11% +$186K ﹤0.01% 2468
2021
Q2
$2.49M Buy
160,332
+29,643
+23% +$460K ﹤0.01% 2309
2021
Q1
$2.12M Buy
130,689
+38,574
+42% +$625K ﹤0.01% 2743
2020
Q4
$1.95M Buy
92,115
+19,369
+27% +$410K ﹤0.01% 2667
2020
Q3
$1.08M Sell
72,746
-499
-0.7% -$7.4K ﹤0.01% 2881
2020
Q2
$1.08M Buy
73,245
+4,834
+7% +$71.1K ﹤0.01% 2887
2020
Q1
$803K Sell
68,411
-45,549
-40% -$535K ﹤0.01% 2915
2019
Q4
$2.68M Buy
113,960
+16,863
+17% +$396K ﹤0.01% 2497
2019
Q3
$1.8M Buy
97,097
+39,223
+68% +$726K ﹤0.01% 2698
2019
Q2
$1.08M Buy
57,874
+17,186
+42% +$320K ﹤0.01% 3015
2019
Q1
$994K Buy
40,688
+3,176
+8% +$77.6K ﹤0.01% 3030
2018
Q4
$973K Sell
37,512
-33,643
-47% -$873K ﹤0.01% 2993
2018
Q3
$2.25M Sell
71,155
-35,280
-33% -$1.12M ﹤0.01% 2627
2018
Q2
$4.14M Sell
106,435
-6,047
-5% -$235K ﹤0.01% 2124
2018
Q1
$3.11M Buy
112,482
+56,643
+101% +$1.56M ﹤0.01% 2285
2017
Q4
$1.01M Buy
55,839
+10,749
+24% +$195K ﹤0.01% 3018
2017
Q3
$728K Buy
45,090
+11,218
+33% +$181K ﹤0.01% 3212
2017
Q2
$469K Buy
33,872
+733
+2% +$10.1K ﹤0.01% 3399
2017
Q1
$497K Buy
33,139
+15,394
+87% +$231K ﹤0.01% 3202
2016
Q4
$232K Sell
17,745
-3,102
-15% -$40.6K ﹤0.01% 3536
2016
Q3
$359K Buy
20,847
+9,029
+76% +$155K ﹤0.01% 3337
2016
Q2
$213K Buy
+11,818
New +$213K ﹤0.01% 3583
2016
Q1
Sell
-49,894
Closed -$1.33M 4002
2015
Q4
$1.33M Buy
49,894
+24,517
+97% +$655K ﹤0.01% 2558
2015
Q3
$619K Buy
25,377
+15,865
+167% +$387K ﹤0.01% 2607
2015
Q2
$296K Buy
+9,512
New +$296K ﹤0.01% 3581